Showing results (121-130 of 771) with videos related to
Sort By:
Pageof 78
Archives of Biochemistry and Biophysics|August 15, 1990
Purification and characterization of three ribonucleases from human kidney: comparison with urine ribonucleasesK Mizuta, S Awazu, T Yasuda, et al.Journal of Pharmacobio-Dynamics|August 1, 1985
Improvement of bioavailability of poorly absorbed drugs. IV. Mechanism of the promoting effect of medium chain glyceride on the rectal absorption of water soluble drugsM Sekine, K Sasahara, R Okada, et al.Journal of Pharmacobio-Dynamics|November 1, 1981
Significance of 17-hydroxycorticosteroid glucuronide in urine as an index of salicylamide glucuronidation in guinea pigsY Sawada, M Hayashi, S Awazu, et al.Biological & Pharmaceutical Bulletin|October 23, 1997
Plasma pharmacokinetics of 7-ethyl-10-hydroxycamptothecin (SN-38) after intravenous administration of SN-38 and irinotecan (CPT-11) to ratsN Kaneda, Y Hosokawa, T Yokokura, et al.Biochimica Et Biophysica Acta|September 29, 1981
Phosphorescence of alkaline phosphatase of E. coli in vitro and in situT Horie, J M VanderkooiJournal of Pharmacokinetics and Biopharmaceutics|August 1, 1978
Correlation between in vitro and in vivo drug metabolism rate: oxidation of ethoxybenzamide in ratJ H Lin, M Hayashi, S Awazu, et al.Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1982
Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological dataJ H Lin, Y Sugiyama, S Awazu, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
Effect of product inhibition on elimination kinetics of ethoxybenzamide in rabbits. Analysis by physiological pharmacokinetic modelJ H Lin, Y Sugiyama, M Hanano, et al.Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1982
In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic modelsJ H Lin, Y Sugiyama, S Awazu, et al.Chemotherapy|January 1, 1981
Pharmacokinetics of cefroxadine in healthy volunteers and patients with impaired renal functionM Ohkawa, K Takamae, M Shimamura, et al.Pageof 78